时间：2026-09-19 20:01:24 来源：网络整理编辑：時尚
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
TopicsHealth
This chart shows just how high Simone Biles can jump2026-09-19 19:53
Chicken salad at Whole Foods recalled for not containing ... chicken2026-09-19 19:43
Mysterious Frankenstein2026-09-19 19:31
Sophie Turner thinks Sansa will probably get killed off on 'Game of Thrones'2026-09-19 18:39
Mall builds real2026-09-19 18:04
The 'Donutella Versace' is a monstrosity of a donut covered in gold flakes2026-09-19 17:59
The Great Barrier Reef is not 'in danger,' UNESCO says2026-09-19 17:42
Blizzard reveals what Doomfist has been up to in 'Overwatch'2026-09-19 17:27
Tributes flow after death of former Singapore president S.R. Nathan2026-09-19 17:24
Blizzard reveals what Doomfist has been up to in 'Overwatch'2026-09-19 17:15
J.K. Rowling makes 'Harry Potter' joke about Olympics event2026-09-19 20:00
Happy aphelion, the day when the Earth is farthest from the sun2026-09-19 19:43
Apple rumored to switch to OLED displays for all iPhones next year2026-09-19 19:28
Dad takes daughter's phone away, follows up with best troll2026-09-19 19:14
Florida hurricane forecast remains uncertain, but trends in state's favor2026-09-19 18:47
The 'Donutella Versace' is a monstrosity of a donut covered in gold flakes2026-09-19 18:34
How to use Facebook's new mobile Find Wi2026-09-19 18:11
Jellybean the joey has just left his mother's pouch and he can't stop bouncing2026-09-19 18:09
Australian football makes history with first LGBT Pride Game2026-09-19 17:20
The Great Barrier Reef is not 'in danger,' UNESCO says2026-09-19 17:19
